Researcher
Ingrid Arijs
- Disciplines:Urology and nephrology
Affiliations
- Nephrology and Renal Transplantation Research Group (Division)
Member
From18 Feb 2019 → 17 May 2019 - Translational Research in GastroIntestinal Disorders (Division)
Member
From1 Jan 2006 → 17 Feb 2019
Projects
1 - 4 of 4
- Molecular characterization of pathophysiologic pathways in IBD and its therapeutic potentialFrom1 Oct 2013 → 16 Nov 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- Identification of the role of matrix metalloproteinases (MMP's) in the development and persistence of chronic bowel inflammation.From1 Jan 2013 → 31 Dec 2016Funding: FWO research project
- The role of matrix metalloproteinases in chronic inflammatory bowel diseases: new insights and applications.From3 Nov 2011 → 31 Dec 2016Funding: IWT personal funding - strategic basic research grants
- Study of the earliest lesions in Crohn's disease in the post-operative recurrence model.From1 Oct 2010 → 31 Oct 2015Funding: FWO fellowships
Publications
91 - 100 of 104
- Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium(2010)
Authors: Mark Zeller, Elisabeth Heylen, Ingrid Arijs, Marc Van Ranst, Jelle Matthijnssens
Pages: 7507 - 7513 - Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab(2010)
Authors: Zhe Li, Ingrid Arijs, Gert De Hertogh, Séverine Vermeire, Dominique Bullens, Xavier Sagaert, Frans Schuit, Paul Rutgeerts, Jan Ceuppens, Gert Van Assche
Pages: 1299 - 1310 - Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis(2009)
Authors: Ingrid Arijs, Roel Quintens, Kristel Van Steen, Gert De Hertogh, Katleen Lemaire, Marc Ferrante, Lieven Thorrez, Gert Van Assche, Séverine Vermeire, Karel Geboes, et al.
Pages: 1612 - 1619 - Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment(2009)
Authors: Ingrid Arijs, Gert De Hertogh, Katleen Lemaire, Roel Quintens, Kristel Van Steen, Isabelle Cleynen, Gert Van Assche, Séverine Vermeire, Karel Geboes, Frans Schuit, et al.
- Mucosal Healing Predicts Long-term Outcome of Maintenance Therapy with Infliximab in Crohn's Disease(2009)
Authors: Marc Ferrante, Ingrid Arijs, Gert Van Assche, Ilse Hoffman, Kristel Van Steen, Séverine Vermeire, Paul Rutgeerts
Pages: 1295 - 1301 - Expression of barrier genes in the colonic mucosa of IBD patients(2009)
Authors: Gert De Hertogh, Ingrid Arijs, Gert Van Assche, Séverine Vermeire, Karel Geboes, Frans Schuit, Paul Rutgeerts
Pages: 89 - 90 - Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort(2009)
Authors: Marc Ferrante, Ingrid Arijs, Gert Van Assche, Ilse Hoffman, Kristel Van Steen, Séverine Vermeire, Paul Rutgeerts
Pages: 492 - 500 - Impaired sulphide detoxification in ulcerative colitis is related to inflammation(2008)
Authors: Vicky De Preter, Ingrid Arijs, Els Houben, Paul Rutgeerts, Kristin Verbeke
Pages: A654 - A655 - Genetic variations in GLI-1 and MDR-1 do not predict disease progression in patients with ulcerative colitis(2008)
Authors: Marc Ferrante, Tamara Coopmans, Isabelle Cleynen, Nathalie Vermeulen, Marie Joossens, Ingrid Arijs, Gert Van Assche, Paul Rutgeerts, Séverine Vermeire
Pages: A457 - A457 - Infliximab does not increase short-term post-operative infectious complications in patients with ulcerative colitis(2008)
Authors: Marc Ferrante, Séverine Vermeire, Sarah Declerck, André D'Hoore, Gert Van Assche, Ilse Hoffman, Isabelle Cleynen, Ingrid Arijs, Marie Joossens, Nathalie Vermeulen, et al.
Pages: A639 - A640